[1] Fan J, Lindemann P, Feuilloley MG, et al. Structural and functional evolution of the translocator protein(18 kDa)[J]. Curr Mol Med, 2012, 12(4):369-386. DOI:10.2174/1566524011207040369.
[2] Crawshaw AA, Robertson NP. The role of TSPO PET in assessing neuroinflammation[J]. J Neurol, 2017, 264(8):1825-1827. DOI:10.1007/s00415-017-8565-1.
[3]

Narayan N, Mandhair H, Smyth E, et al. The macrophage marker translocator protein(TSPO) is down-regulated on pro-inflammatory 'M1' human macrophages[J/OL]. PLoS One, 2017, 12(10): e0185767[2017-11-19]. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28968465. DOI: 10.1371/journal.pone.0185767.eCollection2017.

[4] Shao X, Wang X, English SJ, et al. Imaging of carrageenan-induced local inflammation and adjuvant-induced systemic arthritis with[11C]PBR28PET[J]. Nucl Med Biol, 2013, 40(7):906-911. DOI:10.1016/j.nucmedbio.2013. 06.008.
[5]

Dupont AC, Largeau B, Santiago Ribeiro MJ, et al. Translocator protein-18 kDa (TSPO) positron emission tomography (PET) imaging and its clinical impact in neurodegenerative diseases[J/OL]. Int J Mol Sci, 2017, 18(4): E785[2017-11-19]. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28387722. DOI: 10.3390/ijms18040785.

[6] Wen M, Qu CR, Su XH, et al. A practical process for the synthesis of translocator protein 18 kDa imidazopyridine ligand[J]. Wuhan Univ J Nat Sci, 2014, 19(1):19-26. DOI:10.1007/s11859-014-0973-9.
[7] Su X, Cheng K, Liu Y, et al. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule[J]. Amino Acids, 2015, 47(7):1409-1419. DOI:10.1007/s00726-015-1975-4.
[8] Su X, Cheng K, Jeon J, et al. Comparison of two site-specifically 18F-labeled affibodies for PET imaging of EGFR positive tumors[J]. Mol Pharm, 2014, 11(11):3947-3956. DOI:10.1021/mp5003043.
[9] 豆晓锋, 张亚飞, 蒋怡臻, 等. 131I标记抗NRP-1单克隆抗体A6在荷瘤裸鼠体内分布和显像研究[J].中华核医学与分子影像杂志, 2014, 34(6):495-499. DOI:10.3760/cma.j.issn.2095-2848. 2014.06.017.
Dou XF, Zhang YF, Jiang YZ, et al. Biodistribution and imaging of 131I labeled anti-neuropilin-1 monoclonal antibody in malignant gliomas xenografts[J]. Chin J Nucl Med Mol Imaging, 2014, 34(6):495-499.  doi: 10.3760/cma.j.issn.2095-2848.2014.06.017
[10] Neyt S, Vliegen M, Verreet B, et al. Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study(altered) hepatic transporter function[J]. Nucl Med Biol, 2016, 43(10):642-649. DOI:10.1016/j.nucmedbio.2016. 07.001.
[11] Chang Y, Wu Y, Wang D, et al. Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammstory responses[J]. Rheumatology(Oxford), 2011, 50(5):862-870. DOI:10.1093/rheumatology/keq404.
[12] Laquintana V, Denora N, Musacchio T, et al. Peripheral benzodiazepine receptor ligand-PLGA polymer conjugates potentially useful as delivery systems of apoptotic agents[J]. J Control Release, 2009, 137(3):185-195. DOI:10.1016/j.jconrel.2009. 04.007.
[13] Musacchio T, Laquintana V, Latrofa A, et al. PEG-PE micelles loaded with paclitaxel and surface-modified by a PBR-ligand:synergistic anticancer effect[J]. Mol Pharm, 2009, 6(2):468-479. DOI:10.1021/mp800158c.
[14] 张伟, 蔡亮, 陈跃, 等.双功能制剂99Tcm-Gd-DTPA-DG的制备及在荷瘤裸鼠体内的生物分布[J].中华核医学杂志, 2011, 31(2):117-120. DOI:10.3760/cma.j.issn.0253-9780. 2011.02.011.
Zhang W, Cai L, Chen Y, et al. Synthesis and biodistribution of a bi-functional agent 99Tcm-Gd-DTPA-DG in tumor bearing nude mice[J]. Chin J Nucl Med, 2011, 31(2):117-120.  doi: 10.3760/cma.j.issn.0253-9780.2011.02.011